The step from drug discovery to clinical development is one of the most challenging hurdles, but also one of the most value gaining transformation of a potential drug. The most promising approach is to gain an in-depth understanding of your molecule as well as of the patient population which most likely benefits from treatment. This strategy enables a smart design of a clinical development campaign and contributes to increasing your chances of success.
In this virtual conference representatives from research organizations, Big pharma and CRO industry presented in-depth compound characterizations covering:
